‌

US Patent 6921667 Methods for direct detection of individual methotrexate metabolites

Patent 6921667 was granted and assigned to Prometheus Laboratories on July, 2005 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Prometheus Laboratories

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

69216670

Patent Inventor Names

Russell B. Richerson0

Thierry Dervieux0

Date of Patent

July 26, 2005

Patent Application Number

103840660

Date Filed

March 7, 2003

Patent Primary Examiner

‌

Maureen M. Wallenhorst

Patent abstract

The present invention provides a method for determining a level of a methotrexate polyglutamate (MTXPG) in a cellular extract by resolving at least one MTXPG in a cellular extract obtained from a human undergoing methotrexate therapy; and detecting at least one resolved MTXPG, thereby determining a level of the resolved MTXPG. A method of the invention can be useful, for example, for determining a level of MTXPG3, MTXPG4 or MTXPG5 or for determining a level of each methotrexate polyglutamate species (MTXPG1 to MTXPG7) present in the cellular extract.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 6921667 Methods for direct detection of individual methotrexate metabolites

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API